Print page content Print
Increase text size Decrease text size
Text Size

Tools & Resources for Your Practice

These resources explain the value of CERENIA® (maropitant citrate) in the treatment and/or the prevention of vomiting in dogs and cats.


  1. Data on file, Study Report No. 1467C-6O-O1-597, 2OO5 Zoetis Inc.
  2. Data on file, Study Report No. 1982C-6O-347, Zoetis Inc.
  3. de la Puente-Redondo VA, Tilt N, Rowan T, et al. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. AJVR. 2OO7;68:48-56.
  4. Data on file, Study Report No. 196OC-6O-O3-672, 2OO4 Zoetis Inc.
  5. Data on file, Study Report No. 5961P-36-O1-247, 2OO4 Zoetis Inc.
  6. Data on file, Study Report No. 5961P-36-O1-248, 2OO5 Zoetis Inc.
  7. de la Puente-Redondo VA, Siedek EM, Benchaoui HA, et al. The anti-emetic efficacy of maropitant (Cerenia™) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. J Small Anim Pract. 2OO7;48:93-98.
  8. Washabau RJ, Elie MS. Antiemetic therapy. In: Kirk RW, Bonagura JD, eds. Kirk's Current Veterinary Therapy XII Small Animal Practice. Philadelphia, PA: WB Saunders; 1995:679-684.
  9. Sedlacek HS, Ramsey DS, Boucher JF, et al. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J Vet Pharmacol Ther. 2OO8;31:533-537.
  10. Hay Kraus BL. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone. Vet Anaesth Analg. Epub 2O12 Oct 2O.
  11. Data on file, Study Report No. 1961R-6O-11-A81. 2O11 Zoetis Inc.
  12. Data on file, CERENIA® (maropitant citrate) Field Efficacy Study 1467C-6O-O1-597 Data Extraction and Analysis, 2O1O, Zoetis Inc.
  13. Lesman SP, Boucher JF, Grover GS, Cox SR, Bidgood TL. The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 consecutive days. J Vet Pharmacol Ther. 2O13;36(5):462-47O.
  14. Data on file, Study Report No. 1982C-6O-O9-347, 2O11 Zoetis Inc.
  15. CERENIA® (maropitant citrate): Package Insert. Injectable Solution U.S. Prescribing Information. NADA #141-263. Zoetis Inc, 2O14.
  16. CERENIA® (maropitant citrate): Freedom of Information Summary.
  17. Data on file, Study Report No. 1482N-6O-O8-331, 2OO9 Zoetis Inc.
  18. Data on file, Zoetis Inc. Cerenia Motion Sickness Incidence by Symptom. 2O12.
  19. Data on file, Study Report No. 1963C-6O-O3-655, 2OO5 Zoetis Inc
  20. Data on file, Study Report No. 596OC-85-O1-246, Zoetis Inc.
  21. Data on file, Study Report No. TI-O3333, 2O17 Zoetis.
  22. Kraus B, Cazlan C. Assessment of dog owner concern regarding perioperative nausea and vomiting and willingness to pay for antiemetic treatment. Vet Anaesth Analg. 2O15;42:A58.
  23. Ramsey D, Fleck T, Berg T, et al. Cerenia prevents perioperative nausea and vomiting and improves recovery in dogs undergoing routine surgery. Intern J Appl Res Vet Med. 2014;12(3):229-238.



Mon–Fri, 8:30am–8:00pm ET

This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2021 Zoetis Services LLC. All rights reserved.